Ares Capital: "We do not know what they are really investing in. It has caused a problem. Many people have lost money in these stocks. I would not recommend it."
UBS: "It's not that big. It's 3.28%. Wells [Fargo] has a better yield. You know, I'm starting to warm up again to Wells because I saw that they were coming out of the auto loan industry, which made me think they have a horse sense. [CEO] Charlie Scharf is a good guy. "
Arcturus Therapeutics:" It's probably another RNA spectacle and many people are really interested in RNA. Modern is RNA. It's a speculative stock, as long as you don't put too much of your capital into it. I'll be OK, because I believe in RNA technology. "
Alteryx: It's a purchase.
Lift: "Now you have problems in cities, you have Covid ̵